Stereospecific in vitro and in vivo effects of the new sinus node inhibitor (+)-S 16257

European Journal of Pharmacology
C ThollonJ P Vilaine

Abstract

The effects of the two isomers, (+)-S 16257 and (-)-S 16260, of a new bradycardic agent, (+/-)-S 15544 (7,8-dimethoxy 3-[3-[[(4.5-dimethoxybenzocyclobutan-1-yl)methyl] methylamino]propyl]1,3,4,5-tetrahydro-2H-3-benzazepin-2-one), were compared in vitro and in vivo on cardiac spontaneous rate and repolarization time. In the isolated rabbit sino-atrial node, the three compounds (3 microM) were equi-effective to reduce the action potential firing rate. In anesthetized pigs, both isomers (0.03, 0.1, 0.3 and 1 mg kg(-1) i.v.) were equipotent to reduce heart rate. For all compounds, the negative chronotropic effect resulted from a reduction in the slope of diastolic depolarization of pacemaker cells. In sino-atrial node cells, (-)-S 16260 (3 microM) increased action potential duration while (+)-S 16257 had a smaller effect. In driven guinea-pig papillary muscles exposed to increasing concentrations of compounds (0.1 to 10 microM) a small prolongation of action potential duration was observed. This prolongation was more marked in rabbit Purkinje fibers stimulated at a low rate. In all cardiac preparations the highest prolongation was observed with (-)-S 16260. In vivo, (-)-S 16260 prolonged QTc at the two highest doses tested while (+...Continue Reading

References

Jan 1, 1992·Journal of Cardiovascular Pharmacology·B N Singh
Jan 1, 1992·Journal of Cardiovascular Pharmacology·H S RasmussenH W Dalrymple
Apr 1, 1990·Naunyn-Schmiedeberg's Archives of Pharmacology·T Doerr, W Trautwein
May 1, 1989·Canadian Journal of Physiology and Pharmacology·X Y WeiD J Triggle
Dec 1, 1987·European Heart Journal·W Kobinger, C Lillie
Mar 1, 1982·Journal of Cardiovascular Pharmacology·D W HarronR G Shanks

❮ Previous
Next ❯

Citations

Oct 25, 2003·European Journal of Pharmacology·Pierre Paul Van Bogaert, François Pittoors
Aug 6, 1998·The Annals of Thoracic Surgery·A BelP Menasché
Sep 23, 2008·American Journal of Therapeutics·Jeffrey S Borer, Jean-Yves Le Heuzey
Feb 3, 2006·International Journal of Clinical Practice·S Sulfi, A D Timmis
Nov 26, 2009·Cardiology Research and Practice·Michael LiangGerard Devlin
Sep 14, 2012·Heart Failure Reviews·Maya Guglin
Sep 14, 2007·Journal of Cardiovascular Electrophysiology·Antoun El ChemalyPatrick Bois
Jun 16, 2015·British Journal of Pharmacology·P KleinbongardG Heusch
Apr 7, 2004·British Journal of Pharmacology·Xiao-Jun DuAnthony M Dart
Mar 12, 2016·Expert Review of Cardiovascular Therapy·Christine HenriJean-Claude Tardif
Oct 13, 2009·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Alexandre SarreEric Raddatz
Jun 17, 2003·Journal of Cardiovascular Pharmacology and Therapeutics·Shamil Yusuf, A John Camm
May 10, 2002·Journal of Cardiovascular Pharmacology and Therapeutics·Luyi SenBramah N Singh
Mar 22, 2002·Journal of Cardiovascular Pharmacology and Therapeutics·B N Singh
Mar 6, 2016·Therapeutic Advances in Cardiovascular Disease·Federico Cacciapuoti
Oct 25, 2003·Journal of Cardiovascular Pharmacology·Jean-Paul VilaineJean-Louis Péglion
Dec 16, 2016·Physiological Reviews·Christopher L-H Huang
Apr 26, 2015·Journal of the American Heart Association·Dario MelgariJules C Hancox
Nov 27, 2008·Journal of Cardiovascular Pharmacology·Fanny VaillantPhilippe Chevalier
Jul 16, 2008·Physiological Reviews·Matteo E Mangoni, Joël Nargeot
Jul 3, 2020·Therapeutic Advances in Cardiovascular Disease·Lucia DallapellegrinaEnrico Vizzardi
Jan 15, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Patrice ColinAlain Berdeaux
Nov 26, 2010·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Neeraj Parakh, Balram Bhargava
Sep 12, 2020·American Journal of Respiratory Cell and Molecular Biology·Ryo IshiiMark K Friedberg
Aug 28, 2010·Journal of Medicinal Chemistry·Michele MelchiorreMaria Novella Romanelli

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.